//php print_r(get_the_ID()); ?>
National HPV Vaccination Programme India provides free HPV vaccines to girls aged 14 years to prevent cervical cancer. Launched nationwide in 2026, it targets over 1.15 crore girls annually and uses a single-dose schedule aligned with global guidelines, ensuring accessible and effective prevention.
National HPV Vaccination Programme India marks a major step in India’s public health system, focusing on the prevention of cervical cancer among young girls. Cervical cancer remains one of the most common cancers among women in India, making early prevention crucial.
Through this initiative, the government aims to provide free HPV vaccination for girls in India, ensuring protection against high-risk strains of the human papillomavirus (HPV). The programme reflects a strong commitment to preventive healthcare, women’s health, and equitable access to life-saving vaccines across the country.
National HPV Vaccination Programme India was launched nationwide in 2026 as a mission-mode campaign to protect adolescent girls from cervical cancer. The programme targets approximately 1.15 crore girls aged 14 years every year across all States and Union Territories.
Under this initiative, the HPV vaccine India rollout ensures that eligible beneficiaries receive the vaccine free of cost at government health facilities. The vaccination is voluntary, and parental consent is required before administration.
The programme runs intensively for an initial three-month campaign, after which it continues as part of routine immunization services.
The HPV vaccination rollout India has been implemented across the country through an extensive healthcare network. Vaccination is conducted at:
Each vaccination session is supervised by trained medical officers and supported by healthcare teams. Facilities are equipped with cold chain systems and linked to 24×7 medical support to manage any rare adverse events.
The government has ensured adequate vaccine supply and proper training for seamless implementation across all regions, including rural and underserved areas.
The HPV vaccination programme is a critical part of India’s broader cervical cancer prevention programme.
By preventing HPV infection early, the cervical cancer vaccine India programme significantly reduces the risk of developing cervical cancer later in life. It complements other measures such as screening, early diagnosis, and treatment.
India’s programme uses Gardasil, a quadrivalent human papillomavirus vaccine. It protects against:
Globally, HPV vaccines are among the most studied, with over 500 million doses administered since 2006. Scientific evidence shows 93–100% effectiveness in preventing cervical cancer caused by vaccine-covered types.
Many countries have reported a significant reduction in HPV infections and related diseases after widespread cervical cancer vaccine India.
HPV vaccination for girls India under the national programme is specifically designed to target adolescents at the right age for maximum protection. The programme primarily focuses on girls aged 14 years, covering approximately 1.15 crore beneficiaries annually across all States and Union Territories.
This age group has been selected because vaccination before exposure to HPV ensures maximum effectiveness in preventing infection and future complications. The vaccination is voluntary, and informed consent from parents or guardians is mandatory before administration.
The programme is inclusive and aims to reach girls in urban, rural, and underserved areas through government healthcare infrastructure, ensuring equitable access to preventive care.
The HPV immunization schedule India follows global recommendations.
This simplified schedule offers several advantages:
During the initial three-month campaign, vaccination is available daily at designated centres. After this phase, it becomes part of routine immunization services, ensuring continued access for eligible girls.
The HPV vaccine benefits extend beyond individual protection and contribute significantly to public health. One of the most important advantages is its ability to prevent cervical cancer, which is largely caused by persistent infection with high-risk HPV types.
The vaccine also helps in:
With 93–100% effectiveness, the vaccine is a scientifically proven tool that can significantly reduce cancer burden when widely implemented. Over time, widespread vaccination can lead to a decline in cervical cancer cases and mortality rates.
The HPV vaccine age limit under the national programme primarily focuses on 14-year-old girls, while global guidelines recommend vaccination for individuals aged 9 to 20 years.
With respect to HPV vaccine doses, India has adopted a single-dose vaccination strategy, which is supported by global evidence showing comparable protection to multi-dose schedules. This approach offers key advantages:
By focusing on the right age group and reducing dose complexity, the programme ensures maximum reach and effectiveness.
Under the government HPV vaccination scheme, HPV vaccine cost in India is provided completely free to eligible beneficiaries. This removes financial barriers and ensures that all sections of society can access the vaccine.
The government has secured vaccine supply through a transparent procurement system, supported by global partnerships such as GAVI. All vaccines used are approved by India’s drug regulator and meet strict quality standards.
Government HPV Vaccination Scheme reflects the government’s commitment to:
By making the vaccine free, the programme significantly increases participation and coverage.
The success of the HPV vaccination awareness campaign depends on public participation. The government encourages parents and guardians to ensure vaccination of eligible girls.
With large-scale implementation, the programme aims to:
India now joins over 160 countries that have introduced HPV vaccination, with many already reporting positive outcomes.
The Universal Immunization Programme (UIP) is one of India’s largest public health initiatives, providing free vaccines against multiple life-threatening diseases. The HPV vaccination programme India complements UIP by expanding its scope to include cancer prevention.
UIP already covers vaccines for diseases such as tuberculosis, polio, measles, hepatitis B, and more. By integrating HPV vaccination into the broader immunization ecosystem, the government strengthens its preventive healthcare strategy.
Together, UIP and the HPV vaccination programme play a crucial role in building a healthier and disease-free population.
Check Out UPSC CSE Books
Visit PW Store
National HPV Vaccination Programme India is a government initiative providing free HPV vaccines to 14-year-old girls to prevent cervical cancer.
Girls aged 14 years are eligible under the national programme with parental consent.
Yes, under the government scheme, the vaccine is provided free of cost at public health facilities.
India follows a single-dose schedule based on WHO recommendations.
Vaccination is available at government hospitals, PHCs, CHCs, and medical colleges.
<div class="new-fform">
</div>
